2021
DOI: 10.1016/j.hpb.2020.11.468
|View full text |Cite
|
Sign up to set email alerts
|

ALPPS for Hepatocarcinoma under Cirrhosis: A Feasible Alternative to Portal Vein Embolization

Abstract: Introduction: Advancements in laparoscopic liver resection (LLR) has revolutionized the field of liver surgery. Currently, indocyanine green (ICG) fluorescent image technology is developed as intraoperative navigation tool to detect tumors and demarcation line in LLR. We assessed significance and surgical outcomes of ICG fluorescent surgery in LLR for navigation of demarcation line and intersegmental plane. Methods: We assessed 118 cases who had been performed LLR in our hospital. ICG fluorescent imaging was u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) [51] is gaining momentum as an alternative for liver augmentation for the higher degree and more rapid enlargement of FLR than PVE. The high short-term morbidity and mortality rates reported in the early series have considerably improved over the years due to the establishment of the international ALPPS registry (http:// www.alpps.net/?q=registry) and technical refinements [52]. However, D'Hasse et al reported an unacceptably high 90-day mortality of 31% in patients who underwent ALLPS for HCC (n = 35), which was almost fivefold higher than that for colorectal liver metastases (n = 225; 90day mortality, 7%, p < 0.001) based on the aforementioned registry data.…”
Section: Future Liver Remnant Augmentation: Portal Vein Embolization Versus Alpps Proceduresmentioning
confidence: 99%
“…Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) [51] is gaining momentum as an alternative for liver augmentation for the higher degree and more rapid enlargement of FLR than PVE. The high short-term morbidity and mortality rates reported in the early series have considerably improved over the years due to the establishment of the international ALPPS registry (http:// www.alpps.net/?q=registry) and technical refinements [52]. However, D'Hasse et al reported an unacceptably high 90-day mortality of 31% in patients who underwent ALLPS for HCC (n = 35), which was almost fivefold higher than that for colorectal liver metastases (n = 225; 90day mortality, 7%, p < 0.001) based on the aforementioned registry data.…”
Section: Future Liver Remnant Augmentation: Portal Vein Embolization Versus Alpps Proceduresmentioning
confidence: 99%
“…The first step includes tumor enucleation of the FLR followed by PVE or PVL, while the second step involves major hepatectomy. [70][71][72] Associated liver partition and PVL for staged hepatectomy (ALPPS) is a novel operative procedure consisting of two steps:…”
Section: Advances In Operative Procedures Using Pvementioning
confidence: 99%
“…(a) PVE or PVL and liver transection with or without tumor enucleation from the residual liver, and (b) major hepatectomy. [70][71][72] ALPPS technique has been described to obtain an increased volume of PVE and a decrease in dropout rates. [70][71][72] ALPPS could be a feasible technique only in selected patients with HCC and cirrhosis.…”
Section: Advances In Operative Procedures Using Pvementioning
confidence: 99%
See 2 more Smart Citations